These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3114392)

  • 1. Imipenem resistance in Pseudomonas aeruginosa is due to diminished expression of outer membrane proteins.
    Büscher KH; Cullmann W; Dick W; Wendt S; Opferkuch W
    J Infect Dis; 1987 Oct; 156(4):681-4. PubMed ID: 3114392
    [No Abstract]   [Full Text] [Related]  

  • 2. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.
    Büscher KH; Cullmann W; Dick W; Opferkuch W
    Antimicrob Agents Chemother; 1987 May; 31(5):703-8. PubMed ID: 3111361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of imipenem resistance in Pseudomonas aeruginosa: decreased phenotypic expression of outer membrane proteins D1 and D2].
    Cullmann W; Büscher KH; Opferkuch W
    Immun Infekt; 1986 Nov; 14(6):227-9. PubMed ID: 3100427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the mechanisms involved in imipenem resistance in Pseudomonas aeruginosa isolates from Japan.
    Stunt RA; Thomson CJ; Payne DJ; Amyes SG
    J Antimicrob Chemother; 1998 Aug; 42(2):272-3. PubMed ID: 9738853
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.
    Quinn JP; Dudek EJ; DiVincenzo CA; Lucks DA; Lerner SA
    J Infect Dis; 1986 Aug; 154(2):289-94. PubMed ID: 3088133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
    Giacometti A; Del Prete MS; Cirioni O; Izat MK; Balducci M; Cesarini AM; Scalise G
    J Chemother; 1995 Nov; 7 Suppl 4():76-7. PubMed ID: 8904115
    [No Abstract]   [Full Text] [Related]  

  • 8. Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
    Tausk F; Evans ME; Patterson LS; Federspiel CF; Stratton CW
    Antimicrob Agents Chemother; 1985 Jul; 28(1):41-5. PubMed ID: 3929679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to imipenem in Pseudomonas aeruginosa.
    Lynch MJ; Drusano GL; Mobley HL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1892-6. PubMed ID: 3125787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp].
    Sacha P; Wieczorek P; Jakoniuk P; Zórawski M
    Wiad Lek; 2008; 61(1-3):30-6. PubMed ID: 18717040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem.
    Hostacká A; Karelová E
    Microbios; 1997; 90(362):45-50. PubMed ID: 9301070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Lactamase induction by N-formimidoylthienamycin.
    Grappel SF; Giovenella AJ; Newman DJ; Nisbet LJ
    J Antibiot (Tokyo); 1984 Sep; 37(9):1101-2. PubMed ID: 6438041
    [No Abstract]   [Full Text] [Related]  

  • 14. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY; Ko KS
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of cross-resistance between imipenem and other beta-lactam antibiotics for Pseudomonas aeruginosa.
    Opferkuch W; Cullmann W
    Eur J Clin Microbiol; 1987 Jun; 6(3):330-2. PubMed ID: 3113943
    [No Abstract]   [Full Text] [Related]  

  • 16. Imipenem: morphological changes and lethal effects on Pseudomonas aeruginosa.
    Carlone NA; Ferrero M; Cuffini AM; Cavallo R
    Drugs Exp Clin Res; 1987; 13(10):623-9. PubMed ID: 3123190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
    Tamma PD; Wang R; Lewis S; Opene BNA; Simner PJ
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1378-1379. PubMed ID: 28965496
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa.
    Margaret BS; Drusano GL; Standiford HC
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():161-7. PubMed ID: 2509413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
    Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E
    Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.